The Perceptive team operates with integrity and adheres to the highest set of ethical principles. Our team offers a wealth of industry knowledge with degrees that range from science and medicine to mechanical engineering and finance. We are passionately committed to identifying innovative companies that can drive meaningful change. The Perceptive team has a long and successful track record investing in the life sciences industry.
Chief Executive Officer & Portfolio Manager
Mr. Edelman founded Perceptive Advisors, LLC in 1999. Previously, he was Senior Analyst at Aries Fund, a Paramount Capital Asset Management biotechnology hedge fund, from November 1994 through December 1998. Prior, Joe was Senior Biotechnology Analyst at Prudential Securities for four years. He started his career in the healthcare sector of the securities industry as Biotechnology Analyst at Labe, Simpson. Joe earned an M.B.A. from New York University and a B.A., magna cum laude, in psychology from the University of California San Diego.
Chief Investment Officer
In 2006 Mr. Stone joined Perceptive. Prior to Perceptive he was a senior analyst at Ursus Capital. During his five years there Adam focused on biotech and specialty pharmaceuticals. Adam graduated, with honors, from Princeton University with a B.A. in molecular biology.
Michael Altman, CFA
Mr. Altman joined Perceptive in 2007 from First New York Securities where he was a healthcare analyst. He is focused on medical devices, diagnostics and healthcare services. Michael graduated from the University of Vermont with a B.S. in Finance.
Hossein Ekrami, Ph.D.
Mr. Ekrami joined Perceptive in 2007 from healthcare hedge fund Ursus Capital, where he was a Senior Analyst focused on specialty pharmaceuticals, generics, and biotech for more than seven years. Hossein earned his Ph.D. at the University of Southern California and his undergraduate degree, with honors, from London University.
Craig Yeshion, MD
Dr. Yeshion joined Perceptive in 2016. Prior to joining the firm he was a Portfolio Manager for J. Goldman & Co. covering medical devices and diagnostics from 2012 through 2016. Prior to J. Goldman, he spent 5 years covering medical devices, and biotechnology as a Senior Analyst for Accipiter Capital Management, and 6 years as an analyst for Ursus Capital. Dr. Yeshion received his Medical degree with Honors from the Cornell University Medical College in 1995. He completed his Internal Medicine residency at New York Hospital Cornell Medical Center, and was a physician in private practice from 1995-2000. He received a B.A. in Economics from the University of Pennsylvania.
Ellen Hukkelhoven, Ph.D.
Ms. Hukkelhoven has been with Perceptive since 2013 after earning her Ph.D. at Sloan-Kettering Cancer Center. She graduated magna cum laude from Princeton University with a BA in molecular biology and a certificate in Finance.
Weston Nichols, Ph.D.
Mr. Nichols joined Perceptive in 2016 from Balyasny Asset Management where he was a biotech analyst. He earned his Ph.D. in neuroscience from Caltech, and undergraduate degree in biological engineering from Cornell.
Keyvan Mirsaeedi-Farahani, MD
Mr. Mirsaeedi-Farahani joined Perceptive in 2016 after earning an MD from the University of Pennsylvania and an MBA from the Harvard Business School. He previously spent two years as an analyst with McKinsey. Keyvan graduated Phi Beta Kappa from the University of Michigan with a BS in molecular biology as well as an undergraduate business degree.
Mr. Chawla brings over 15 years of experience in healthcare corporate finance to Perceptive. Prior to joining in 2013, he was Managing Director in the Global Healthcare Group at UBS Investment Bank. Sam has in-depth experience in M&A advisory, underwriting debt and equity financings across healthcare. Sam graduated from Johns Hopkins University with a B.A. in Economics and from Georgetown University with a MBA.
Chief Credit Officer
Mr. Dixit brings 15 years of experience to Perceptive. He was formerly Managing Director, Fort Hill Investment Partners and a Vice President at Fortress Investment Group, Drawbridge Special Opportunities Fund. Sandeep has an extensive credit structuring, underwriting and portfolio management background encompassing direct lending, leveraged loans and high yield bonds. He graduated cum laude with a B.S. in Economics from The Wharton School, University of Pennsylvania.